Codagenix Inc. Employee Directory
Biotechnology ResearchNew York, United States11-50 Employees
Codagenix is a clinical-stage biotechnology company based in Farmingdale, New York, focused on vaccines and immuno-oncology therapies. It advances candidates for influenza, RSV, dengue, and other pathogens by applying a computational design approach that preserves the amino acid sequence while reducing viral protein production in human cells, yielding highly attenuated viruses suitable for vaccines or oncolytic use. A substantial portion of its pipeline explores intranasal, live-attenuated vaccine formats, including programs for RSV and other respiratory diseases. Its products are intended for public health vaccination programs and oncology indications, addressing viral infections and solid tumors through preventive and therapeutic approaches. In October 2023, Codagenix announced positive clinical data for CoviLiv, its COVID-19 vaccine candidate, presented at the IDWeek 2023 conference.